About
Dr. Ananthu S Manoj is a physician and healthcare technology founder based in Kerala, India.
He is Founder and Designated Partner of NeuroHue Therapeutics LLP, a digital health company building clinical technology for neurodevelopmental care — assessment, therapy monitoring, and interpretation tools used by institutions, clinicians, therapists and families.
Work on the underlying clinical systems began in 2021. NeuroHue was founded in 2025 by Dr. Ananthu S Manoj, and NeuroHue Therapeutics LLP was formally incorporated in India in 2026, once the approach had been tested in practice. Its systems are now operational across multiple institutions in India, with a pilot deployment underway in Malaysia adapted to different clinical structures.
01
Background
Ananthu S Manoj trained in medicine at Vydehi Institute of Medical Sciences and Research Centre.
His approach to building clinical technology comes from practice rather than from software. The problems NeuroHue Therapeutics addresses were encountered in clinical settings first, and the systems are designed around how developmental care is actually delivered rather than how it is described.
02
NeuroHue Therapeutics
The company builds structured assessment and therapy-monitoring systems for neurodevelopmental care. Three patent applications have been filed in India, covering neurodevelopmental assessment methodology, therapy monitoring, and data-driven clinical systems.
The work sits between three things that rarely meet: clinical practice, developmental science, and the design of systems clinicians will actually use in the room.
Deployment partners are not named publicly. Clinical institutions work under confidentiality, and that is respected here.
03
Current work
His work spans neurodevelopmental care, digital therapeutics, clinical analytics, machine learning in healthcare, and clinical workflow design.
He is currently developing healthcare-focused foundational models and building structured clinical and behavioural datasets intended to support the training and evaluation of artificial intelligence systems in medicine — an area where the shortage of well-structured clinical data is a greater constraint than model capability.
04
Research
Alongside the company's clinical systems, he maintains an ongoing programme of exploratory research into behavioural interpretation, developmental signal analysis, and the interpretive frameworks underlying developmental assessment.
This research is early-stage and distinct from the deployed systems.